Alexza Pharmaceuticals Inc (NASDAQ:ALXA)

CAPS Rating: 4 out of 5

An emerging pharmaceutical company focused on the development and commercialization of novel, proprietary products for the treatment of acute and intermittent conditions.

Recs

0
Player Avatar rauorski (25.49) Submitted: 10/31/2010 5:05:04 AM : Outperform Start Price: $1.05 ALXA Score: -76.42

Good drug.. will get approval!!!

Featured Broker Partners


Advertisement